Total Payments
$5,341
2024 Payments
$16.38
Companies
31
Transactions
512
Medicare Patients
3,502
Medicare Billing
$201,251
Payment Breakdown by Category
Food & Beverage$5,307 (99.4%)
Education$33.96 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,307 | 508 | 99.4% |
| Education | $33.96 | 4 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,244 | 175 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $545.00 | 38 | $0 (2023) |
| Merck Sharp & Dohme LLC | $530.12 | 61 | $0 (2023) |
| AbbVie Inc. | $478.32 | 59 | $0 (2023) |
| Amgen Inc. | $320.45 | 26 | $0 (2023) |
| PFIZER INC. | $305.02 | 25 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $295.44 | 15 | $0 (2024) |
| Lilly USA, LLC | $255.60 | 19 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $159.75 | 11 | $0 (2019) |
| Amarin Pharma Inc. | $132.52 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.38 | 1 | AstraZeneca Pharmaceuticals LP ($16.38) |
| 2023 | $315.43 | 19 | Novo Nordisk Inc ($76.56) |
| 2022 | $1,150 | 104 | ABBVIE INC. ($293.10) |
| 2021 | $764.45 | 76 | Novo Nordisk Inc ($170.23) |
| 2020 | $632.00 | 62 | Novo Nordisk Inc ($172.69) |
| 2019 | $824.33 | 84 | Novo Nordisk Inc ($222.31) |
| 2018 | $800.73 | 83 | Novo Nordisk Inc ($253.71) |
| 2017 | $837.54 | 83 | Novo Nordisk Inc ($194.20) |
All Payment Transactions
512 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Respiratory | ||||||
| 09/27/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Diabetes | ||||||
| 09/21/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.75 | General |
| 04/26/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.71 | General |
| Category: Cardiovascular | ||||||
| 04/24/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Obesity | ||||||
| 04/10/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Urology | ||||||
| 04/05/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Inflammation | ||||||
| 03/22/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Oncology | ||||||
| 03/20/2023 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 03/15/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Bone Health | ||||||
| 03/13/2023 | PFIZER INC. | PREVNAR 13 (Biological), PREVNAR 20, COMIRNATY | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: VACCINES | ||||||
| 03/08/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Respiratory | ||||||
| 02/27/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Diabetes | ||||||
| 02/20/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/15/2023 | Merck Sharp & Dohme LLC | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/13/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: VACCINES | ||||||
| 02/08/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug), LIVALO | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: PAIN MANAGEMENT | ||||||
| 02/01/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Diabetes | ||||||
| 01/23/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Diabetes | ||||||
| 12/30/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Diabetes | ||||||
| 12/19/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Diabetes | ||||||
| 12/14/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Diabetes | ||||||
| 12/14/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.05 | General |
| Category: Diabetes | ||||||
| 12/12/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 330 | 385 | $57,393 | $22,868 |
| 2022 | 11 | 894 | 1,218 | $149,892 | $51,850 |
| 2021 | 20 | 1,171 | 1,646 | $152,738 | $69,566 |
| 2020 | 23 | 1,107 | 1,598 | $127,035 | $56,967 |
Total Patients
3,502
Total Services
4,847
Medicare Billing
$201,251
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 40 | 40 | $11,200 | $10,976 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 122 | 147 | $25,835 | $5,802 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 58 | 75 | $9,375 | $3,057 | 32.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 34 | 34 | $7,820 | $1,560 | 20.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 37 | 37 | $1,110 | $1,086 | 97.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 26 | 35 | $1,645 | $333.20 | 20.3% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 13 | 17 | $408.00 | $52.87 | 13.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 167 | 358 | $62,705 | $15,390 | 24.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 126 | 126 | $9,444 | $8,636 | 91.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 124 | 197 | $24,625 | $7,742 | 31.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 29 | 29 | $7,970 | $7,584 | 95.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 145 | 145 | $33,330 | $6,592 | 19.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 132 | 132 | $3,960 | $3,690 | 93.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 32 | 32 | $960.00 | $898.36 | 93.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 48 | 92 | $4,324 | $883.34 | 20.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 24 | 24 | $1,128 | $185.68 | 16.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 42 | 42 | $462.00 | $125.49 | 27.2% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 25 | 41 | $984.00 | $123.38 | 12.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 162 | 352 | $61,355 | $27,977 | 45.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 151 | 263 | $32,555 | $14,511 | 44.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 60 | 60 | $13,440 | $7,694 | 57.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 96 | 96 | $6,757 | $6,265 | 92.7% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 15 | 16 | $4,100 | $2,233 | 54.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 117 | 117 | $3,510 | $1,894 | 54.0% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 22 | 22 | $1,540 | $1,436 | 93.2% |
About Dr. David Ware, M.D
Dr. David Ware, M.D is a Family Medicine healthcare provider based in Findlay, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760445084.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Ware, M.D has received a total of $5,341 in payments from pharmaceutical and medical device companies, with $16.38 received in 2024. These payments were reported across 512 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($5,307).
As a Medicare-enrolled provider, Ware has provided services to 3,502 Medicare beneficiaries, totaling 4,847 services with total Medicare billing of $201,251. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Findlay, OH
- Active Since 04/08/2006
- Last Updated 03/05/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1760445084
Products in Payments
- Ozempic (Drug) $436.09
- JANUVIA (Drug) $318.07
- SOLIQUA 100/33 (Biological) $276.21
- Victoza (Drug) $245.37
- JARDIANCE (Drug) $244.28
- UBRELVY (Drug) $216.04
- Tresiba (Drug) $191.12
- Saxenda (Drug) $181.12
- Vascepa (Drug) $132.52
- SOLIQUA (Drug) $124.59
- NURTEC ODT (Drug) $121.01
- Kerendia (Drug) $118.65
- Aimovig (Biological) $113.25
- QULIPTA (Drug) $111.75
- Livalo (Drug) $106.30
- TRINTELLIX (Drug) $96.23
- TRULICITY (Drug) $94.44
- Hyalomatrix Wound Device (Device) $91.46
- ENTRESTO (Drug) $89.05
- Rybelsus (Drug) $88.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Findlay
Dr. Thomas Grace, M.d, M.D
Family Medicine — Payments: $441,282
Family Medicine $441,282
Dr. Scott Rioch, D.o, D.O
Family Medicine — Payments: $18,175
Family Medicine $18,175
Kathryn Karhoff, Do, DO
Family Medicine — Payments: $2,926
Family Medicine $2,926
Dr. Donald Johnson, D.o, D.O
Family Medicine — Payments: $1,730
Family Medicine $1,730
Dr. William Hopkins, M.d, M.D
Family Medicine — Payments: $1,727
Family Medicine $1,727
Michael Manuel, M.d, M.D
Family Medicine — Payments: $1,361
Family Medicine $1,361